Growth hormone in musculoskeletal pain states

被引：9

作者：

Bennett R. ^{[1
]}

机构：

[1] Oregon Health and Science University, Department of Medicine, Portland, OR 97201

来源：

Current Pain and Headache Reports | 2005年 / 9卷 / 5期

关键词：

Growth Hormone; Fibromyalgia; Acromegaly; Growth Hormone Deficiency; Growth Hormone Secretion;

D O I：

10.1007/s11916-005-0009-4

中图分类号：

学科分类号：

摘要：

Growth hormone is essential for normal linear growth and the attainment of an adult mature height. It also plays an important role in cartilage growth and the attainment of normal bone mass. There is only one rheumatic disorder, namely acromegaly, in which abnormalities of growth hormone production play a major etiologic role. However, there is increasing appreciation that suboptimal growth hormone secretion, leading to a state of adult growth hormone deficiency, may occur in the setting of chronic inflammatory disease, chronic corticosteroid use, and fibromyalgia. Therefore, the evaluation and effective management of growth hormone oversecretion and undersecretion is relevant to practicing rheumatologists. Copyright © 2005 by Current Science Inc.

引用

页码：331 / 338

页数：7

共 47 条

[1]

Giustina A., Veldhuis J.D., Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human, Endocr. Rev., 19, pp. 717-797, (1998)

[2]

Otero M., Nogueiras R., Lago F., Et al., Ghrelin plasmatic levels in patients with fibromyalgia, Rheumatol. Int., (2003)

[3]

Dons R.F., Rosselet P., Pastakia B., Et al., Arthropathy in acromegalic patients before and after treatment: A long-term follow-up study, Clin. Endocrinol. (Oxf.), 28, pp. 515-524, (1988)

[4]

Lieberman S.A., Bjorkengren A.G., Hoffman A.R., Rheumatologic and skeletal changes in acromegaly, Endocrinol. Metab. Clin. North Am., 21, pp. 615-631, (1992)

[5]

Scarpa R., De Brasi D., Pivonello R., Et al., Acromegalic axial arthropathy: A clinical case-control study, J. Clin. Endocrinol. Metab., 89, pp. 598-603, (2004)

[6]

Altomonte L., Zoli A., Mirone L., Et al., Growth hormone secretion in diffuse idiopathic skeletal hyperostosis, Ann. Ital. Med. Int., 7, pp. 30-33, (1992)

[7]

Denko C.W., Boja B., Growth hormone, insulin, and insulin-like growth factor-1 in hypermobility syndrome, J. Rheumatol., 28, pp. 1666-1669, (2001)

[8]

Schouten J.S., Van den Ouweland F.A., Valkenburg H.A., Lamberts S.W., Insulin-like growth factor-1: A prognostic factor of knee osteoarthritis, Br. J. Rheumatol., 32, pp. 274-280, (1993)

[9]

Hochberg M.C., Lethbridge-Cejku M., Scott Jr. W.W., Et al., Serum levels of insulin-like growth factor in subjects with osteoarthritis of the knee. Data from the Baltimore Longitudinal Study of Aging, Arthritis Rheum., 37, pp. 1177-1180, (1994)

[10]

Jamal G.A., Kerr D.J., McLellan A.R., Et al., Generalized peripheral nerve dysfunction in acromegaly: A study by conventional and novel neurophysiological techniques, J. Neurol. Neurosurg. Psychiatry, 50, pp. 886-894, (1987)

← 1 2 3 4 5 →